What is the main difference between emerging and reemerging infectious diseases?

Infectious diseases pose a critical threat to global health security with high morbidity, mortality, and healthcare costs. Many infectious agents have emerged and reemerged in recent decades due to the dynamic host–pathogen interactions, partially driven by anthropogenic selection, niche adaptation and climate change. These factors present major challenges to the public health and agricultural systems through the constant need for the development of cost-effective diagnosis, prevention, and therapeutic strategies, in addition to maintaining real-time epidemiological surveillance. Current control measures based on rapid diagnosis, conventional vaccination, quarantine, and culling of affected animals have not been sufficient to stop those emerging and re-emerging infectious diseases, including ASFV in pigs and COVID-19 in humans, from becoming major veterinary public health issues to the globe public health crisis.

In response to this, the Special Issue “Emerging and Re-emerging Infectious Diseases” will focus on COVID-19, ASFV, Ebola, Influenza, ZIKA, and other recent bacterial, parasitic, fungal diseases of major veterinary and public health importance.

Topics of interest include:

  • Molecular surveillance and epidemiology 
  • Clinical investigation of emerging or re-emerging infectious disease, including newly characterized zoonotic pathogens or their variants
  • Innovative strategies for pathogen detection, drug and vaccine development, and disease control and prevention
  • Influence of global warming on emerging and re-emerging diseases
  • One health, biosecurity and public health issues related to pathogen emergence or re-emergence
  • Review or opinion regarding timely emerging or re-emerging infectious disease, including policy and planning for the control of infections
  • Other explorative research in understanding pathogen and host interactions within the topic

Editorial Board

Guest Editor: Lihua Xiao

Associate Editor of Animal Diseases
Professor of Veterinary Parasitology, South China Agricultural University, China
Email:

Guest Editor: Min Yue 

Board member of Animal Diseases
Professor of Epidemiology, Department of Veterinary Medicine, Zhejiang University, China
Email:

Science Editor: Fang He

Board member of Animal Diseases
Professor of Veterinary Virology, Department of Veterinary Medicine, Zhejiang University, China
Email:

Science Editor: Wentao Li

Professor of Veterinary Virology, College of Animal Sciences & Technology, Huazhong Agricultural University, China
Email:

  1. Development of a chromatographic lateral flow immunoassay for detection of African swine fever virus antigen in blood

    African swine fever (ASF) is a highly lethal disease of domestic and wild swine caused by African swine fever virus (ASFV). The disease currently circulates in Africa, Europe, Asia and on the island of Hispani...

    Authors: Daniel W. Madden, Sun-Young Sunwoo, Natasha N. Gaudreault, Jessie D. Trujillo, Igor Morozov, Carmina Gallardo and Juergen A. Richt

    Citation: Animal Diseases 2022 2:14

    Content type: Original Article Published on: 21 June 2022

    • View Full Text
    • View PDF
  2. African swine fever virus MGF505-3R inhibits cGAS-STING-mediated IFN-β pathway activation by degrading TBK1

    African swine fever virus (ASFV) is an important pathogen causing acute infectious disease in domestic pigs and wild boars that seriously endangers the global swine industry. As ASFV is structurally complex an...

    Authors: Mingyang Cheng, Jiawei Luo, Yuetong Duan, Yu Yang, Chunwei Shi, Yu Sun, Yiyuan Lu, Junhong Wang, Xiaoxu Li, Jianzhong Wang, Nan Wang, Wentao Yang, Yanlong Jiang, Guilian Yang, Yan Zeng, Chunfeng Wang…

    Citation: Animal Diseases 2022 2:13

    Content type: Original Article Published on: 20 June 2022

    • View Full Text
    • View PDF
  3. Maternal-derived antibodies hinder the antibody response to H9N2 AIV inactivated vaccine in the field

    The H9N2 subtype avian influenza virus (AIV) inactivated vaccine has been used extensively in poultry farms, but it often fails to stimulate a sufficiently high immune response in poultry in the field, althoug...

    Authors: Xue Pan, Xin Su, Pingyun Ding, Jinhua Zhao, Hongrui Cui, Dawei Yan, Qiaoyang Teng, Xuesong Li, Nancy Beerens, Haitao Zhang, Qinfang Liu, Mart C. M. de Jong and Zejun Li

    Citation: Animal Diseases 2022 2:9

    Content type: Original Article Published on: 6 May 2022

    • View Full Text
    • View PDF

How are emerging infectious diseases different from regular infectious diseases?

Emerging infectious diseases are infections that have recently appeared within a population or those whose incidence or geographic range is rapidly increasing or threatens to increase in the near future.

What is emerging and re

PIP: Emerging infectious diseases are diseases of infectious origin whose incidence in humans has increased within the past decades or threatens to increase in the near future. The reappearance of a previously known infection after a period of disappearance or decline in incidence is known as re-emergence.

What is an emerging infectious diseases?

Emerging infectious diseases can be defined as infectious diseases that have newly appeared in a population or have existed but are rapidly increasing in incidence or geographic range, or that are caused by one of the NIAID Category A, B, or C priority pathogens.

What is the common symptoms of the emerging and re

Early disease symptoms include vomiting, diarrhea, and fever; later symptoms include intense muscle pain because the larvae grow and mature in those tissues. Fatal cases often show congestive heart failure and respiratory paralysis.